Radiology Oncology Surgical Robots Market
WinterGreen Research announces that it has published a new study Radiology Oncology Surgical Robots: Market Shares, Strategy, and Forecasts, Worldwide, 2016 to 2022. The 2016 study has 557 pages, 82 tables and figures. Worldwide Radiology Oncology surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and use radiology for cancer surgery. New systems pinpoint the delivery of radiation precisely, eliminating the radiological overdosing that has been such a problem previously, limiting the quantity of radiation that can be delivered.
Radiosurgery robots take cancer surgery far beyond what has been available, promising a cure for cancer. Radiology oncology surgical robots use mechanical mobility and continuous image guidance to remove tumors. The Accuray CyberKnife® robotic system follows the oncology target throughout treatment, intelligently delivering sub-millimeter precision, sparing healthy tissue. A robotic manipulator and a compact, lightweight linear accelerator, can deliver beams from thousands of noncoplanar, isocentric or non-isocentric angles. Treatments have excellent tumor coverage, steep dose gradients, and tight dose conformality.
The radiation oncology market is growing globally due to a number of factors centered around the aging of the population and the benefits accrued from new technology. The number of new cancer cases diagnosed annually is projected to increase from 14.9 million in 2015 to 20 million by 2025. The increase in new cases is due to a steadily aging population. Both developed and developing countries have aging populations.
Technology advances improve the precision and applicability of radiotherapy and radiosurgery. Expanding uses of radiotherapy and radiosurgery equipment occur because the units are able to treat a broader range of cases. Advances in hardware and software are creating a market for replacing an aging installed base. New designs are able to deliver higher standards of care.
The rise in cancer cases, together with the increase in sophistication of new treatment protocols, have created demand for more automated products. Automation depends on integration of several devices into clinically practical systems. Integrated systems make treatments rapid and cost effective.
Technology advances lead to improvements in patient care. The availability of advanced, automated and efficient clinical tools in radiation therapy has brought more precise forms of radiotherapy treatment (IMRT, IGRT, VMAT, SRS, SBRT, brachytherapy and proton therapy). Technology includes the EDGE™ and Truebeam™, and the Accuray TomoTherapy H Series and CyberKnife M6 platforms that enable treatments that reduce treatment times and increase patient throughput .
International markets are under-equipped to address the growing cancer incidence. Patients in many foreign countries must frequently endure long waits for radiotherapy. 9,000 additional treatment machines will be required by 2020 in developing countries. China, India and Brazil are estimated to require over 3,800, 1,200 and 400 additional machines. Demand in emerging markets, coupled with ever increasing incidences of cancer, represent additional drivers for continued growth.
Radiology oncology surgical robot market driving forces relate to an opportunity to achieve change in medical practice regarding the treatment of cancer. Change would lead to utilization of stereotactic body radiosurgery more regularly as an alternative to surgery or other treatments. Radiosurgery is poised to revolutionize the treatment of cancer by eradicating tumors while not harming surrounding healthy tissue.
The ability to use high doses of radiation to precisely eliminate a tumor while leaving healthy tissue unharmed is compelling. It means that high doses of radiation can be delivered without killing the person, that doses of radiation delivered can be enough to kill the cancer without killing the person, this represents a change in what has been possible previously.
The Varian, Elekta, and Accuray radiology oncology surgical devices offer robust clinical treatment capabilities. Flexibility of the Accuray InCise™ Multileaf Collimator and robotic delivery permit treatment of tumors previously thought untreatable. With radiosurgery and SBRT cancer can be treated efficiently and effectively. The device offers accuracy.
According to Susan Eustis, lead author of the study, “Existing open brain and abdominal cancer surgery can be replaced in large part during the forecast period by robotic radiological oncology surgery. Radiologic robotic surgical approaches complement existing open surgery techniques, but will replace them as more physicians and surgeons become skilled in manipulating the x-ray devices. Soon, all oncology surgery will be considered in the context of what part of the oncology procedure will be undertaken with at least some aspects of robotic radiologic surgery replacing or complementing open cancer surgery.
The aging US population has supported demand for robotic Radiology Oncology surgery. Since the occurrence of health issues that require medical devices is higher in the elderly population the more astute baby boomers have been looking to understand what surgical alternatives are open to them. . Buoyed by strong demand and sales, industry profit margins have increased considerably during the past five years.
Hospitals are adopting robotic surgical devices to improve their outcomes numbers. Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly. Hundreds of universities worldwide have research programs in robotics and many are awarding degrees in robotics. These “roboticists” are increasingly being hired by Global 2000 organizations to link mobile robots (mobile computers) into existing IT systems.
Robot-assisted surgery gives the surgeon better control over the surgical instruments and a better view of the surgical site. Surgeons no longer have to stand throughout the surgery and do not tire as quickly. Hand tremors are filtered out by the robot’s computer software. The surgical robot can continuously be used by rotating surgery teams.
Radiology Oncology surgical robot device markets at $4 billion in 2015 are anticipated to reach $7.3 billion by 2022 as next generation devices, systems, and instruments are introduced to manage cancer surgery through radiation excision that eliminates open cutting in the body. Patients tolerate the surgery well, walking out of the hospital after the procedure no longer bothered by healing or infection from an incision.
The complete report provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success, challenges, and strategies in each segment and sub-segment. The reports cover markets for Radiology Oncology robotic surgery medical specialties and sub-specialties.
WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, Bloomberg, and Thompson Financial. It conducts its business with integrity.
WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, Bloomberg, and Thompson Financial. WinterGreen Research is positioned to help customers facing challenges that define the modern enterprises. The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise. Customers trust wintergreen research to work alongside them to ensure the success of the participation in a particular market segment.
WinterGreen Research supports various market segment programs; provides trusted technical services to the marketing departments. It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally. These are all vital market research support solutions requiring trust and integrity.
Radiosurgery robots take cancer surgery far beyond what has been available, promising a cure for cancer. Radiology oncology surgical robots use mechanical mobility and continuous image guidance to remove tumors. The Accuray CyberKnife® robotic system follows the oncology target throughout treatment, intelligently delivering sub-millimeter precision, sparing healthy tissue. A robotic manipulator and a compact, lightweight linear accelerator, can deliver beams from thousands of noncoplanar, isocentric or non-isocentric angles. Treatments have excellent tumor coverage, steep dose gradients, and tight dose conformality.
The radiation oncology market is growing globally due to a number of factors centered around the aging of the population and the benefits accrued from new technology. The number of new cancer cases diagnosed annually is projected to increase from 14.9 million in 2015 to 20 million by 2025. The increase in new cases is due to a steadily aging population. Both developed and developing countries have aging populations.
Technology advances improve the precision and applicability of radiotherapy and radiosurgery. Expanding uses of radiotherapy and radiosurgery equipment occur because the units are able to treat a broader range of cases. Advances in hardware and software are creating a market for replacing an aging installed base. New designs are able to deliver higher standards of care.
The rise in cancer cases, together with the increase in sophistication of new treatment protocols, have created demand for more automated products. Automation depends on integration of several devices into clinically practical systems. Integrated systems make treatments rapid and cost effective.
Technology advances lead to improvements in patient care. The availability of advanced, automated and efficient clinical tools in radiation therapy has brought more precise forms of radiotherapy treatment (IMRT, IGRT, VMAT, SRS, SBRT, brachytherapy and proton therapy). Technology includes the EDGE™ and Truebeam™, and the Accuray TomoTherapy H Series and CyberKnife M6 platforms that enable treatments that reduce treatment times and increase patient throughput .
International markets are under-equipped to address the growing cancer incidence. Patients in many foreign countries must frequently endure long waits for radiotherapy. 9,000 additional treatment machines will be required by 2020 in developing countries. China, India and Brazil are estimated to require over 3,800, 1,200 and 400 additional machines. Demand in emerging markets, coupled with ever increasing incidences of cancer, represent additional drivers for continued growth.
Radiology oncology surgical robot market driving forces relate to an opportunity to achieve change in medical practice regarding the treatment of cancer. Change would lead to utilization of stereotactic body radiosurgery more regularly as an alternative to surgery or other treatments. Radiosurgery is poised to revolutionize the treatment of cancer by eradicating tumors while not harming surrounding healthy tissue.
The ability to use high doses of radiation to precisely eliminate a tumor while leaving healthy tissue unharmed is compelling. It means that high doses of radiation can be delivered without killing the person, that doses of radiation delivered can be enough to kill the cancer without killing the person, this represents a change in what has been possible previously.
The Varian, Elekta, and Accuray radiology oncology surgical devices offer robust clinical treatment capabilities. Flexibility of the Accuray InCise™ Multileaf Collimator and robotic delivery permit treatment of tumors previously thought untreatable. With radiosurgery and SBRT cancer can be treated efficiently and effectively. The device offers accuracy.
According to Susan Eustis, lead author of the study, “Existing open brain and abdominal cancer surgery can be replaced in large part during the forecast period by robotic radiological oncology surgery. Radiologic robotic surgical approaches complement existing open surgery techniques, but will replace them as more physicians and surgeons become skilled in manipulating the x-ray devices. Soon, all oncology surgery will be considered in the context of what part of the oncology procedure will be undertaken with at least some aspects of robotic radiologic surgery replacing or complementing open cancer surgery.
The aging US population has supported demand for robotic Radiology Oncology surgery. Since the occurrence of health issues that require medical devices is higher in the elderly population the more astute baby boomers have been looking to understand what surgical alternatives are open to them. . Buoyed by strong demand and sales, industry profit margins have increased considerably during the past five years.
Hospitals are adopting robotic surgical devices to improve their outcomes numbers. Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly. Hundreds of universities worldwide have research programs in robotics and many are awarding degrees in robotics. These “roboticists” are increasingly being hired by Global 2000 organizations to link mobile robots (mobile computers) into existing IT systems.
Robot-assisted surgery gives the surgeon better control over the surgical instruments and a better view of the surgical site. Surgeons no longer have to stand throughout the surgery and do not tire as quickly. Hand tremors are filtered out by the robot’s computer software. The surgical robot can continuously be used by rotating surgery teams.
Radiology Oncology surgical robot device markets at $4 billion in 2015 are anticipated to reach $7.3 billion by 2022 as next generation devices, systems, and instruments are introduced to manage cancer surgery through radiation excision that eliminates open cutting in the body. Patients tolerate the surgery well, walking out of the hospital after the procedure no longer bothered by healing or infection from an incision.
The complete report provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players’ success, challenges, and strategies in each segment and sub-segment. The reports cover markets for Radiology Oncology robotic surgery medical specialties and sub-specialties.
WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, Bloomberg, and Thompson Financial. It conducts its business with integrity.
WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, Bloomberg, and Thompson Financial. WinterGreen Research is positioned to help customers facing challenges that define the modern enterprises. The increasingly global nature of science, technology and engineering is a reflection of the implementation of the globally integrated enterprise. Customers trust wintergreen research to work alongside them to ensure the success of the participation in a particular market segment.
WinterGreen Research supports various market segment programs; provides trusted technical services to the marketing departments. It carries out accurate market share and forecast analysis services for a range of commercial and government customers globally. These are all vital market research support solutions requiring trust and integrity.
1. RADIOLOGY SURGICAL ROBOT MARKET DESCRIPTION AND MARKET DYNAMICS
1.1 Radiotherapy, Radiation Therapy, Radiosurgery, And Brachytherapy Market Description
1.1.1 IMRT
1.1.2 VMAT
1.1.3 IGRT
1.1.4 SRS and SBRT
1.1.5 Brachytherapy
1.1.6 Proton Therapy
1.2 Current Radiation Therapy Limitations
1.3 Radiology Robotic Surgical Clinical Facilities and Clinical Diagnosis
1.3.1 Cancer Robotic Surgery Learning Curves
1.3.2 Robotic Radiological Surgery Equipment
1.3.3 Medicare and Medicaid Impact
1.3.4 Medical Robotic Surgery by Segment
1.3.5 Robotic Cancer Surgery
1.3.6 Cancer
1.4 Brain Tumors
1.4.1 Causes of Brain Tumor
1.4.2 Tumor Grading
1.4.3 Types of Treatment
1.4.4 Biopsies
1.4.5 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products
2. RADIOLOGY ONCOLOGY SURGICAL ROBOT MARKET SHARES AND MARKET FORECASTS
2.1 Radiology Oncology Surgical Robot Market Driving Forces
2.1.1 Surgical Radiology Robotics Market Driving Forces
2.1.2 Radiology Surgical Robot Key Procedures As Elements Of Strategy
2.1.3 Radiosurgery Is Stereotactic Radiotherapy
2.2 Radiology Oncology Surgical Robots Market Share Analysis
2.2.1 Accuray
2.2.2 Accuray Clinical Studies
2.2.3 Accuray Goal
2.2.4 Accuray Revenue
2.2.5 Varian
2.2.6 Elekta
2.2.7 Brainlab
2.2.8 Radiology Surgical Robots Market Unit Analysis
2.3 Radiology Surgical Robots Market Forecasts
2.3.1 Advanced Surgical Robotic Radiation Therapy Systems
2.3.2 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products
2.4 Cancer Incidence and Radiology Surgery Number of Procedures
2.5 Radiology Surgical Robots Regional Analysis
2.5.1 US Radiation Oncology Market
2.5.2 European Radiation Oncology Market
2.5.3 Asia Pacific Market Radiation Oncology Market
2.5.4 Accuray in China
2.5.5 Advantages of the Accuray Cyberknife treatment in China
2.5.6 GE Moves X-Ray Base to China to Tap Growth
2.5.7 Japanese Regulatory Approval for Accuray CyberKnife Robotic Full-body Radiosurgery System
2.5.8 Japan X-ray Systems Market
2.5.9 Philips Expands Global Reach Of X-Ray Solutions
2.5.10 Reimbursement Challenges
3. RADIOLOGY SURGICAL ROBOTS PRODUCT DESCRIPTIONS
3.1 Accuray CyberKnife M6 Series
3.1.1 Accuray CyberKnife M6 FIM System
3.1.2 Accuray CyberKnife® M6™ System
3.1.3 Accuray / CyberKnife VSI System
3.1.4 Accuray / TomoTherapy System
3.1.5 Accuray Clinical Studies
3.1.6 Accuray TomoTherapy® System Clinical Studies
3.1.7 Accuray CyberKnife® System Clinical Study
3.1.8 Accuray TomoTherapy System Clinical Study
3.1.9 Class A User Licenses for Accuray Products Awarded to 16 Hospitals in China
3.1.10 Accuray “Open Systems” Software Benefits
3.2 Elekta
3.2.1 Elekta Gamma Knife® Surgery
3.3 Varian
3.3.1 Varian Image Guided Radiation Therapy, Cone-Beam CT (CBCT
3.3.2 Varian Trilogy
3.3.3 Varian Edge™ Radiosurgery Suite
3.3.4 Varian Oncology Systems
3.4 ViewRay
4. RADIOLOGY SURGICAL ROBOTS TECHNOLOGY AND RESEARCH
4.1 Accuray Radiology to Treat Head Cancer And Spinal Cancer
4.1.1 Fiducial Markers Implantation
4.1.2 Molding Of A Plastic Body Cradle
4.1.3 Treatment Planning
4.1.4 Programming of the Accuray Cyberknife System
4.1.5 Treatment Procedure
4.1.6 Postoperative Supervision
4.2 Varian Medical TrueBeam® Systems Advanced Platform
4.2.1 Potential of High Definition Radiotherapy
4.3 C-Arm Surgical X-Rays
4.4 X-Ray Digital Workflow
4.5 Stereotactic Radiosurgery
4.5.1 Image-Guided Stereotactic Radiosurgery
4.5.2 Image-Guided Stereotactic Radiosurgery Safety
4.6 Siemens Ysio Max (Advances in X-Ray)
4.7 MD Anderson Gamma Knife Radiosurgery
4.7.1 MD Anderson Proton Therapy Center
4.8 Partners Healthcare Massachusetts General Hospital Radiation Cancer Treatment
4.8.1 Partners Healthcare / Dana Farber
4.8.2 Three-Dimensional Conformal Radiation Therapy (3D-CRT)
4.8.3 Image Guided Radiation Therapy (IGRT)
4.8.4 Intensity Modulated Radiation Therapy (IMRT)
4.8.5 RapidArc™ Volumetric Modulated Radiotherapy
4.8.6 Total Body Irradiation (TBI)
4.8.7 Accelerated Whole Breast Radiation Therapy
4.8.8 Stereotactic Radiosurgery (SRS)
4.8.9 High Dose Rate (HDR) Brachytherapy
4.8.10 Robotic Transrectal Ultrasound (TRUS) Guided Radiation Therapy
4.9 Memorial Sloan Kettering Radiation Cancer Treatment
4.9.1 Memorial Sloan Kettering IMRT & IGRT
4.9.2 Memorial Sloan Kettering Stereotactic Radiation Therapy
4.9.3 Memorial Sloan Kettering Whole-Brain Radiation Therapy Stereotactic Radiosurgery, SRS
4.10 U.S. Regulations
4.10.1 Foreign Regulations
5. RADIOLOGY SURGICAL ROBOTS COMPANY DESCRIPTIONS
5.1 Accuray
5.1.1 Accuray Revenue for Second Quarter of Fiscal Year 2015
5.1.2 Accuray Revenue Three Months Ended September 2015
5.1.3 Accuray Revenue
5.1.4 Accuray Non-Invasively Delivers High Doses Of Radiation To Tumors With Extreme Accuracy And Intense Precision
5.1.5 Accuray Products
5.1.6 Accuray CyberKnife System
5.1.7 Accuray Strategy
5.1.8 Accuray International Presence
5.1.9 Accuray Competition
5.1.10 New Data Validates CyberKnife SBRT for Prostate Cancer Treatment
5.1.11 Accuray Recall in 2013
5.2 Best Theratronics, Ltd
5.3 Brainlab AG
5.3.1 Brainlab AG Revenue
5.3.2 Brainlab
5.4 Elekta
5.4.1 Elekta Gamma Radio Surgery System
5.4.2 Elekta - Interim report May – October 2015/16
5.4.3 Elekta Transformation program on track
5.5 Mitsubishi Heavy Industries
5.5.1 Mitsubishi Heavy Industries Vero Sterotactic Body Radiotherapy
5.6 Varian Medical Systems
5.6.1 Varian Oncology Systems Business Segment
5.6.2 Varian Revenue
5.7 ViewRay
5.8 Accuray Locations
5.9 2D X-ray Equipment Leading Vendors
1.1 Radiotherapy, Radiation Therapy, Radiosurgery, And Brachytherapy Market Description
1.1.1 IMRT
1.1.2 VMAT
1.1.3 IGRT
1.1.4 SRS and SBRT
1.1.5 Brachytherapy
1.1.6 Proton Therapy
1.2 Current Radiation Therapy Limitations
1.3 Radiology Robotic Surgical Clinical Facilities and Clinical Diagnosis
1.3.1 Cancer Robotic Surgery Learning Curves
1.3.2 Robotic Radiological Surgery Equipment
1.3.3 Medicare and Medicaid Impact
1.3.4 Medical Robotic Surgery by Segment
1.3.5 Robotic Cancer Surgery
1.3.6 Cancer
1.4 Brain Tumors
1.4.1 Causes of Brain Tumor
1.4.2 Tumor Grading
1.4.3 Types of Treatment
1.4.4 Biopsies
1.4.5 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products
2. RADIOLOGY ONCOLOGY SURGICAL ROBOT MARKET SHARES AND MARKET FORECASTS
2.1 Radiology Oncology Surgical Robot Market Driving Forces
2.1.1 Surgical Radiology Robotics Market Driving Forces
2.1.2 Radiology Surgical Robot Key Procedures As Elements Of Strategy
2.1.3 Radiosurgery Is Stereotactic Radiotherapy
2.2 Radiology Oncology Surgical Robots Market Share Analysis
2.2.1 Accuray
2.2.2 Accuray Clinical Studies
2.2.3 Accuray Goal
2.2.4 Accuray Revenue
2.2.5 Varian
2.2.6 Elekta
2.2.7 Brainlab
2.2.8 Radiology Surgical Robots Market Unit Analysis
2.3 Radiology Surgical Robots Market Forecasts
2.3.1 Advanced Surgical Robotic Radiation Therapy Systems
2.3.2 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products
2.4 Cancer Incidence and Radiology Surgery Number of Procedures
2.5 Radiology Surgical Robots Regional Analysis
2.5.1 US Radiation Oncology Market
2.5.2 European Radiation Oncology Market
2.5.3 Asia Pacific Market Radiation Oncology Market
2.5.4 Accuray in China
2.5.5 Advantages of the Accuray Cyberknife treatment in China
2.5.6 GE Moves X-Ray Base to China to Tap Growth
2.5.7 Japanese Regulatory Approval for Accuray CyberKnife Robotic Full-body Radiosurgery System
2.5.8 Japan X-ray Systems Market
2.5.9 Philips Expands Global Reach Of X-Ray Solutions
2.5.10 Reimbursement Challenges
3. RADIOLOGY SURGICAL ROBOTS PRODUCT DESCRIPTIONS
3.1 Accuray CyberKnife M6 Series
3.1.1 Accuray CyberKnife M6 FIM System
3.1.2 Accuray CyberKnife® M6™ System
3.1.3 Accuray / CyberKnife VSI System
3.1.4 Accuray / TomoTherapy System
3.1.5 Accuray Clinical Studies
3.1.6 Accuray TomoTherapy® System Clinical Studies
3.1.7 Accuray CyberKnife® System Clinical Study
3.1.8 Accuray TomoTherapy System Clinical Study
3.1.9 Class A User Licenses for Accuray Products Awarded to 16 Hospitals in China
3.1.10 Accuray “Open Systems” Software Benefits
3.2 Elekta
3.2.1 Elekta Gamma Knife® Surgery
3.3 Varian
3.3.1 Varian Image Guided Radiation Therapy, Cone-Beam CT (CBCT
3.3.2 Varian Trilogy
3.3.3 Varian Edge™ Radiosurgery Suite
3.3.4 Varian Oncology Systems
3.4 ViewRay
4. RADIOLOGY SURGICAL ROBOTS TECHNOLOGY AND RESEARCH
4.1 Accuray Radiology to Treat Head Cancer And Spinal Cancer
4.1.1 Fiducial Markers Implantation
4.1.2 Molding Of A Plastic Body Cradle
4.1.3 Treatment Planning
4.1.4 Programming of the Accuray Cyberknife System
4.1.5 Treatment Procedure
4.1.6 Postoperative Supervision
4.2 Varian Medical TrueBeam® Systems Advanced Platform
4.2.1 Potential of High Definition Radiotherapy
4.3 C-Arm Surgical X-Rays
4.4 X-Ray Digital Workflow
4.5 Stereotactic Radiosurgery
4.5.1 Image-Guided Stereotactic Radiosurgery
4.5.2 Image-Guided Stereotactic Radiosurgery Safety
4.6 Siemens Ysio Max (Advances in X-Ray)
4.7 MD Anderson Gamma Knife Radiosurgery
4.7.1 MD Anderson Proton Therapy Center
4.8 Partners Healthcare Massachusetts General Hospital Radiation Cancer Treatment
4.8.1 Partners Healthcare / Dana Farber
4.8.2 Three-Dimensional Conformal Radiation Therapy (3D-CRT)
4.8.3 Image Guided Radiation Therapy (IGRT)
4.8.4 Intensity Modulated Radiation Therapy (IMRT)
4.8.5 RapidArc™ Volumetric Modulated Radiotherapy
4.8.6 Total Body Irradiation (TBI)
4.8.7 Accelerated Whole Breast Radiation Therapy
4.8.8 Stereotactic Radiosurgery (SRS)
4.8.9 High Dose Rate (HDR) Brachytherapy
4.8.10 Robotic Transrectal Ultrasound (TRUS) Guided Radiation Therapy
4.9 Memorial Sloan Kettering Radiation Cancer Treatment
4.9.1 Memorial Sloan Kettering IMRT & IGRT
4.9.2 Memorial Sloan Kettering Stereotactic Radiation Therapy
4.9.3 Memorial Sloan Kettering Whole-Brain Radiation Therapy Stereotactic Radiosurgery, SRS
4.10 U.S. Regulations
4.10.1 Foreign Regulations
5. RADIOLOGY SURGICAL ROBOTS COMPANY DESCRIPTIONS
5.1 Accuray
5.1.1 Accuray Revenue for Second Quarter of Fiscal Year 2015
5.1.2 Accuray Revenue Three Months Ended September 2015
5.1.3 Accuray Revenue
5.1.4 Accuray Non-Invasively Delivers High Doses Of Radiation To Tumors With Extreme Accuracy And Intense Precision
5.1.5 Accuray Products
5.1.6 Accuray CyberKnife System
5.1.7 Accuray Strategy
5.1.8 Accuray International Presence
5.1.9 Accuray Competition
5.1.10 New Data Validates CyberKnife SBRT for Prostate Cancer Treatment
5.1.11 Accuray Recall in 2013
5.2 Best Theratronics, Ltd
5.3 Brainlab AG
5.3.1 Brainlab AG Revenue
5.3.2 Brainlab
5.4 Elekta
5.4.1 Elekta Gamma Radio Surgery System
5.4.2 Elekta - Interim report May – October 2015/16
5.4.3 Elekta Transformation program on track
5.5 Mitsubishi Heavy Industries
5.5.1 Mitsubishi Heavy Industries Vero Sterotactic Body Radiotherapy
5.6 Varian Medical Systems
5.6.1 Varian Oncology Systems Business Segment
5.6.2 Varian Revenue
5.7 ViewRay
5.8 Accuray Locations
5.9 2D X-ray Equipment Leading Vendors
LIST OF TABLES AND FIGURES
Table ES-1 Innovative Radiology Surgical Robot Features
Table ES-2 Surgical Robotics Market Driving Forces
Table ES-3 Radiology Surgical Robot Market Positioning
Table ES-4 Accuray CyberKnife M6 Series Systems Adoption Trends
Table ES-5 Radiological Surgical Robot Medical Sub-Specialties
Figure ES-6 Radiology Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2015
Figure ES-7 Radiology Surgical Robot Systems Forecasts, Dollars, Worldwide, 2015-2021
Table 1-1 Current Radiation Therapy Process and Limitations
Table 1-2 Advanced Clinical Decision Support
Table 1-3 Radiological Surgical Robots Benefits
Figure 1-4 X-ray Diagnosing and Tracking Cancer
Table 1-5 Factors That May Increase The Risk Of Complications With Radiology Cancer Surgery
Table 1-6 X-Ray Equipment Market Driving Forces
Table 2-1 Innovative Radiology Surgical Robot Features
Table 2-2 Surgical Robotics Market Driving Forces
Table 2-3 Radiology Surgical Robot Market Positioning
Table 2-4 Accuray CyberKnife M6 Series Systems Adoption Trends
Table 2-5 Radiological Surgical Robot Medical Sub-Specialties
Figure 2-6 Radiology Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2015
Table 2-7 Radiology Surgical Linear Accelerator Market Shares, Dollars, Worldwide, 2015
Figure 2-8 Accuray Patient Station
Table 2-9 Accuray CyberKnife Features
Table 2-10 Accuray Regional Revenue Shifts
Table 2-11 Elekta Gamma Knife Benefits
Table 2-12 Elekta Gamma Knife® Positioning
Table 2-13 Elekta Gamma Knife Perfexion Treatment Benefits
Table 2-14 Elekta Gamma Knife Features
Table 2-15 Radiology Surgical Linear Accelerator, Market Shares, Units and Dollars, Worldwide, 2015
Figure 2-16 Radiology Surgical Robot Systems Forecasts, Dollars, Worldwide, 2016-2022
Table 2-17 Radiology Surgical Robot Market Segment Forecasts, Dollars and Units, Worldwide, 2016-2022
Table 2-18 New Cancer Cases in US
Figure 2-19 Cancer Incidence and Mortality, Worldwide
Table 2-20 Accuray Surgical Robotic Advantages
Figure 2-21 Radiology Surgical Robots Regional Analysis
Table 2-22 Radiology Surgical Robots Market Segments
Table 2-23 Accuray Regional Revenue Shifts
Table 2-24 Accuray Cyberknife Radiosurgery System Treats The Following Diseases In China:
Table 2-25 Advantages of the Cyberknife Treatment in China
Table 3-1 Accuray CyberKnife M6 Series Benefits:
Table 3-2 Accuray CyberKnife M6 Series Functions
Table 3-3 Accuray CyberKnife M6 Series Uses
Table 3-4 Accuray CyberKnife M6 Series Features
Table 3-5 Accuray CyberKnife M6 Patient Comfort Features
Figure 3-6 Accuray Radiology Surgical Robot
Figure 3-7 Accuray CyberKnife M6 FIM System
Table 3-8 Accuray CyberKnife M6 FIM System Features
Figure 3-9 Accuray CyberKnife M6 FM System
Table 3-10 Accuray CyberKnife M6 FM System Design Features
Figure 3-11 Accuray CyberKnife M6 FI System
Figure 3-12 Accuray / CyberKnife VSI System
Table 3-13 Accuray CyberKnife VSI™ Radiosurgery System Functions
Table 3-14 Accuray CyberKnife VSI™ Radiosurgery System Treatment Options
Figure 3-15 Accuray TomoTherapy® System
Table 3-16 Accuray TomoTherapy System Benefits
Table 3-17 Accuray Cancer Conditions Treated via Surgical Robot
Table 3-18 Accuray Open Systems Software Benefits
Table 3-19 Accuray Open Systems Software Challenges
Figure 3-20 Human Brain with Cancer Tumors
Figure 3-21 Elekta Lexsell Gamma Knife® PERFEXIONTM System
Table 3-22 Conditions for Elekta Gamma Knife® Efficacy
Table 3-23 Advantages of Elekta Gamma Knife®
Figure 3-24 Elekta Market Leading Solutions Portfolio
Figure 3-25 Varian Radiosurgery System
Figure 3-26 Varian Radiation Surgery Capabilities
Figure 3-27 Varian Trilogy
Table 3-28 Varian Oncology Product Set
Table 3-28 (Continued) Varian Oncology Product Set
Figure 3-29 ViewRay On-Table Dose Prediction And Re-Optimization
Figure 3-30 ViewRay MRIdian® System
Table 3-31 ViewRay MRIdian® System Functions
Figure 4-1 X-Ray Digital Workflow
Figure 4-2 Digital X-Ray Equ9pm3n35 Part of Paperless Workflow in Hospital
Figure 4-3 Departmental Picture Archiving And Communication System PACS: Clinical Productivity
Table 4-4 Elekta Gamma Knife Surgery Targets Accuray Regional Revenue Shifts
Table 5-1 Accuray Strategy
Table 5-2 Accuray Key Elements Of Strategy
Table 5-3 Best Theratronics, Ltd Radiation Therapy - Gammabeam™ 500 Total Body Irradiator Features
Figure 5-4 Best Theratronics, Ltd Radiation Therapy - Gammabeam™ 500 Total Body Irradiator
Figure 5-5 Brainlab Collaborative Workspace
Figure 5-6 Brainlab AG Worldwide Presence, Headquarters in Germany
Figure 5-7 Elekta Gamma Radio Surgery System
Figure 5-8 Mitsubishi Heavy Industries Vero RadioTherapy
Table 5-9 ViewRay Early Adopters:
Table ES-1 Innovative Radiology Surgical Robot Features
Table ES-2 Surgical Robotics Market Driving Forces
Table ES-3 Radiology Surgical Robot Market Positioning
Table ES-4 Accuray CyberKnife M6 Series Systems Adoption Trends
Table ES-5 Radiological Surgical Robot Medical Sub-Specialties
Figure ES-6 Radiology Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2015
Figure ES-7 Radiology Surgical Robot Systems Forecasts, Dollars, Worldwide, 2015-2021
Table 1-1 Current Radiation Therapy Process and Limitations
Table 1-2 Advanced Clinical Decision Support
Table 1-3 Radiological Surgical Robots Benefits
Figure 1-4 X-ray Diagnosing and Tracking Cancer
Table 1-5 Factors That May Increase The Risk Of Complications With Radiology Cancer Surgery
Table 1-6 X-Ray Equipment Market Driving Forces
Table 2-1 Innovative Radiology Surgical Robot Features
Table 2-2 Surgical Robotics Market Driving Forces
Table 2-3 Radiology Surgical Robot Market Positioning
Table 2-4 Accuray CyberKnife M6 Series Systems Adoption Trends
Table 2-5 Radiological Surgical Robot Medical Sub-Specialties
Figure 2-6 Radiology Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2015
Table 2-7 Radiology Surgical Linear Accelerator Market Shares, Dollars, Worldwide, 2015
Figure 2-8 Accuray Patient Station
Table 2-9 Accuray CyberKnife Features
Table 2-10 Accuray Regional Revenue Shifts
Table 2-11 Elekta Gamma Knife Benefits
Table 2-12 Elekta Gamma Knife® Positioning
Table 2-13 Elekta Gamma Knife Perfexion Treatment Benefits
Table 2-14 Elekta Gamma Knife Features
Table 2-15 Radiology Surgical Linear Accelerator, Market Shares, Units and Dollars, Worldwide, 2015
Figure 2-16 Radiology Surgical Robot Systems Forecasts, Dollars, Worldwide, 2016-2022
Table 2-17 Radiology Surgical Robot Market Segment Forecasts, Dollars and Units, Worldwide, 2016-2022
Table 2-18 New Cancer Cases in US
Figure 2-19 Cancer Incidence and Mortality, Worldwide
Table 2-20 Accuray Surgical Robotic Advantages
Figure 2-21 Radiology Surgical Robots Regional Analysis
Table 2-22 Radiology Surgical Robots Market Segments
Table 2-23 Accuray Regional Revenue Shifts
Table 2-24 Accuray Cyberknife Radiosurgery System Treats The Following Diseases In China:
Table 2-25 Advantages of the Cyberknife Treatment in China
Table 3-1 Accuray CyberKnife M6 Series Benefits:
Table 3-2 Accuray CyberKnife M6 Series Functions
Table 3-3 Accuray CyberKnife M6 Series Uses
Table 3-4 Accuray CyberKnife M6 Series Features
Table 3-5 Accuray CyberKnife M6 Patient Comfort Features
Figure 3-6 Accuray Radiology Surgical Robot
Figure 3-7 Accuray CyberKnife M6 FIM System
Table 3-8 Accuray CyberKnife M6 FIM System Features
Figure 3-9 Accuray CyberKnife M6 FM System
Table 3-10 Accuray CyberKnife M6 FM System Design Features
Figure 3-11 Accuray CyberKnife M6 FI System
Figure 3-12 Accuray / CyberKnife VSI System
Table 3-13 Accuray CyberKnife VSI™ Radiosurgery System Functions
Table 3-14 Accuray CyberKnife VSI™ Radiosurgery System Treatment Options
Figure 3-15 Accuray TomoTherapy® System
Table 3-16 Accuray TomoTherapy System Benefits
Table 3-17 Accuray Cancer Conditions Treated via Surgical Robot
Table 3-18 Accuray Open Systems Software Benefits
Table 3-19 Accuray Open Systems Software Challenges
Figure 3-20 Human Brain with Cancer Tumors
Figure 3-21 Elekta Lexsell Gamma Knife® PERFEXIONTM System
Table 3-22 Conditions for Elekta Gamma Knife® Efficacy
Table 3-23 Advantages of Elekta Gamma Knife®
Figure 3-24 Elekta Market Leading Solutions Portfolio
Figure 3-25 Varian Radiosurgery System
Figure 3-26 Varian Radiation Surgery Capabilities
Figure 3-27 Varian Trilogy
Table 3-28 Varian Oncology Product Set
Table 3-28 (Continued) Varian Oncology Product Set
Figure 3-29 ViewRay On-Table Dose Prediction And Re-Optimization
Figure 3-30 ViewRay MRIdian® System
Table 3-31 ViewRay MRIdian® System Functions
Figure 4-1 X-Ray Digital Workflow
Figure 4-2 Digital X-Ray Equ9pm3n35 Part of Paperless Workflow in Hospital
Figure 4-3 Departmental Picture Archiving And Communication System PACS: Clinical Productivity
Table 4-4 Elekta Gamma Knife Surgery Targets Accuray Regional Revenue Shifts
Table 5-1 Accuray Strategy
Table 5-2 Accuray Key Elements Of Strategy
Table 5-3 Best Theratronics, Ltd Radiation Therapy - Gammabeam™ 500 Total Body Irradiator Features
Figure 5-4 Best Theratronics, Ltd Radiation Therapy - Gammabeam™ 500 Total Body Irradiator
Figure 5-5 Brainlab Collaborative Workspace
Figure 5-6 Brainlab AG Worldwide Presence, Headquarters in Germany
Figure 5-7 Elekta Gamma Radio Surgery System
Figure 5-8 Mitsubishi Heavy Industries Vero RadioTherapy
Table 5-9 ViewRay Early Adopters: